{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:33Z","timestamp":1792291053046,"version":"4.4.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.disamonth.2023.101606","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T10:13:18Z","timestamp":1687601598000},"page":"101606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ulcerative colitis: Addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates"],"prefix":"10.1016","volume":"69","author":[{"given":"Mohammed Dheyaa Marsool","family":"Marsool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Dheyaa Marsool","family":"Marsool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Narreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Gadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshi","family":"Prajjwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0001","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gutjnl-2012-302311","article-title":"Work disability in inflammatory bowel disease patients 10\u2005years after disease onset: results from the IBSEN study","volume":"62","author":"H\u00f8ivik","year":"2012","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.disamonth.2023.101606_bib0002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ibd.22839","article-title":"Ulcerative colitis as a progressive disease: the forgotten evidence","volume":"18","author":"Torres","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"9","key":"10.1016\/j.disamonth.2023.101606_bib0003","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0004","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ibd.21815","article-title":"Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts","volume":"18","author":"Magro","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.disamonth.2023.101606_bib0005","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","article-title":"The epidemiology of inflammatory bowel disease in Canada: a population-based study [published correction appears in Am J Gastroenterol. 2006 Aug;101(8):1945]","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101606_bib0006","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101606_bib0007","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0008","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101606_bib0009","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.39.5.690","article-title":"Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)","volume":"39","author":"Shivananda","year":"1996","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2013-304636","article-title":"East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort","volume":"63","author":"Burisch","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0011","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ajg.2015.52","article-title":"Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study","volume":"110","author":"Benchimol","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123599","article-title":"Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort study","volume":"10","author":"Benchimol","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.disamonth.2023.101606_bib0013","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/j.1572-0241.1999.01438.x","article-title":"The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994)","volume":"94","author":"Carr","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","article-title":"Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study","volume":"145","author":"Ng","year":"2013","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.disamonth.2023.101606_bib0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/gut.52.11.1587","article-title":"Incidence and prevalence of ulcerative colitis in Punjab, North India","volume":"52","author":"Sood","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MCG.0b013e3181574636","article-title":"Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey","volume":"43","author":"Tozun","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/S0004-28032009000100009","article-title":"Incidence and prevalence rates of inflammatory bowel diseases, in Midwestern of S\u00e3o Paulo State, Brazil","volume":"46","author":"Victoria","year":"2009","journal-title":"Arq Gastroenterol"},{"issue":"10114","key":"10.1016\/j.disamonth.2023.101606_bib0018","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies [published correction appears in Lancet. 2020 Oct 3;396(10256):e56]","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0019","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0020","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/jcag\/gwy051","article-title":"The impact of inflammatory bowel disease in Canada 2018: IBD in seniors","volume":"2","author":"Nguyen","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101606_bib0021","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1155\/2015\/136960","article-title":"Characterization of inflammatory bowel disease in elderly patients: a review of epidemiology, current practices and outcomes of current management strategies","volume":"29","author":"Stepaniuk","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0022","first-page":"S1","article-title":"The impact of inflammatory bowel disease in Canada 2018: a scientific report from the Canadian gastro-intestinal epidemiology consortium to Crohn's and colitis Canada","volume":"2","author":"Benchimol","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0023","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrgastro.2013.241","article-title":"Clinical implications of ageing for the management of IBD","volume":"11","author":"Ha","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.disamonth.2023.101606_bib0024","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"10080","key":"10.1016\/j.disamonth.2023.101606_bib0025","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2023.101606_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0027","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101606_bib0028","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0029","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0030","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0016-5085(00)70007-2","article-title":"Therapy of inflammatory bowel disease","volume":"118","author":"Sands","year":"2000","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.disamonth.2023.101606_bib0031","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/gut.2003.035758","article-title":"Iron, anaemia, and inflammatory bowel diseases","volume":"53","author":"Gasche","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0032","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0034","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.thromres.2014.12.025","article-title":"Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study","volume":"135","author":"Chung","year":"2015","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.disamonth.2023.101606_bib0035","first-page":"711","article-title":"Extracolonic diagnoses in ulcerative colitis: an epidemiological study","volume":"85","author":"Mons\u00e9n","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0036","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.disamonth.2023.101606_bib0037","first-page":"S198","article-title":"How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? [published correction appears in Inflamm Bowel Dis. 2009 Sep;15(9):1438-47]","volume":"14","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.disamonth.2023.101606_bib0038","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1440-1746.2005.03905.x","article-title":"Inflammatory bowel disease in Iran: a review of 457 cases","volume":"20","author":"Aghazadeh","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0039","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"issue":"30","key":"10.1016\/j.disamonth.2023.101606_bib0040","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0041","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(94)90066-3","article-title":"A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody","volume":"107","author":"Bhagat","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0042","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"31","author":"Su","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0043","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications","volume":"77","author":"Rankin","year":"1979","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.disamonth.2023.101606_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2004.02055.x","article-title":"Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease","volume":"20","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.disamonth.2023.101606_bib0046","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1155\/2005\/323914","article-title":"Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease","volume":"19","author":"Freeman","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101606_bib0047","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0048","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00054725-199805000-00025","article-title":"Cutaneous manifestations of inflammatory bowel disease","volume":"4","author":"Lebwohl","year":"1998","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0049","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15","author":"Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"46","key":"10.1016\/j.disamonth.2023.101606_bib0050","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0051","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MEG.0000000000000532","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an update","volume":"28","author":"Rossi","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.disamonth.2023.101606_bib0052","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2023.101606_bib0053","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0054","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.disamonth.2023.101606_bib0055","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0056","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.disamonth.2023.101606_bib0057","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bpg.2009.10.011","article-title":"Gastrointestinal and liver adverse effects of drugs used for treating IBD","volume":"24","author":"Rogler","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0058","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ecco-jcc\/jjv178","article-title":"Ocular manifestations in inflammatory bowel disease are associated with other extra-intestinal manifestations, gender, and genes implicated in other immune-related traits","volume":"10","author":"Taleban","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"32","key":"10.1016\/j.disamonth.2023.101606_bib0059","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","article-title":"Ophthalmic manifestations in patients with inflammatory bowel disease: a review","volume":"23","author":"Troncoso","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2023.101606_bib0061","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0033-8389(22)02224-2","article-title":"Genitourinary complications of inflammatory bowel disease","volume":"25","author":"Banner","year":"1987","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.disamonth.2023.101606_bib0062","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00054725-200111000-00003","article-title":"Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998","volume":"7","author":"Wester","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.disamonth.2023.101606_bib0063","doi-asserted-by":"crossref","unstructured":"Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol. 2002;97(2):377-381. doi:10.1111\/j.1572-0241.2002.05473.x.","DOI":"10.1111\/j.1572-0241.2002.05473.x"},{"key":"10.1016\/j.disamonth.2023.101606_bib0064","doi-asserted-by":"crossref","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, et\u00a0al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol 2019; 114:384. doi:10.14309\/ajg.0000000000000152.","DOI":"10.14309\/ajg.0000000000000152"},{"key":"10.1016\/j.disamonth.2023.101606_bib0065","doi-asserted-by":"crossref","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625. doi:10.1056\/NEJM198712243172603.","DOI":"10.1056\/NEJM198712243172603"},{"key":"10.1016\/j.disamonth.2023.101606_bib0066","doi-asserted-by":"crossref","unstructured":"Ko CW, Singh S, Feuerstein JD, et\u00a0al. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology 2019; 156:748. doi:10.1053\/j.gastro.2018.12.009.","DOI":"10.1053\/j.gastro.2018.12.009"},{"key":"10.1016\/j.disamonth.2023.101606_bib0067","doi-asserted-by":"crossref","unstructured":"Singh S, Ananthakrishnan AN, Nguyen NH, et\u00a0al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology 2023; 164:344. doi:10.1053\/j.gastro.2022.12.007.","DOI":"10.1053\/j.gastro.2022.12.007"},{"key":"10.1016\/j.disamonth.2023.101606_bib0068","doi-asserted-by":"crossref","unstructured":"Dassopoulos T, Cohen RD, Scherl EJ, et\u00a0al. Ulcerative colitis care pathway. Gastroenterology 2015; 149:238. doi:10.1053\/j.gastro.2015.05.036.","DOI":"10.1053\/j.gastro.2015.05.036"},{"key":"10.1016\/j.disamonth.2023.101606_bib0069","doi-asserted-by":"crossref","unstructured":"Dias CC, Rodrigues PP, da Costa-Pereira A, Magro F. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis 2015; 9:156. doi:10.1093\/ecco-jcc\/jju016.","DOI":"10.1093\/ecco-jcc\/jju016"},{"key":"10.1016\/j.disamonth.2023.101606_bib0070","doi-asserted-by":"crossref","unstructured":"Rodgers AD, Cummins AG. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease. Dig Dis Sci 2007; 52:2063. doi:10.1007\/s10620-006-9691-2.","DOI":"10.1007\/s10620-006-9691-2"},{"key":"10.1016\/j.disamonth.2023.101606_bib0071","doi-asserted-by":"crossref","unstructured":"Prantera C, Davoli M, Lorenzetti R, et\u00a0al. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 1988; 10:41. doi:10.1097\/00004836-198802000-00010.","DOI":"10.1097\/00004836-198802000-00010"},{"key":"10.1016\/j.disamonth.2023.101606_bib0072","doi-asserted-by":"crossref","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:661. doi:10.1097\/00054725-200409000-00026.","DOI":"10.1097\/00054725-200409000-00026"},{"key":"10.1016\/j.disamonth.2023.101606_bib0073","doi-asserted-by":"crossref","unstructured":"Schoepfer AM, Trummler M, Seeholzer P, et\u00a0al. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008; 14:32. doi:10.1002\/ibd.20275.","DOI":"10.1002\/ibd.20275"},{"key":"10.1016\/j.disamonth.2023.101606_bib0074","doi-asserted-by":"crossref","unstructured":"Poullis AP, Zar S, Sundaram KK, et\u00a0al. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol 2002; 14:409. doi:10.1097\/MCG.0000000000000327.","DOI":"10.1097\/00042737-200204000-00013"},{"key":"10.1016\/j.disamonth.2023.101606_bib0075","doi-asserted-by":"crossref","unstructured":"Marshall JK, Thabane M, Steinhart AH, et\u00a0al. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010;:CD004115. doi:10.1002\/14651858.CD004115.pub2.","DOI":"10.1002\/14651858.CD004115.pub2"},{"key":"10.1016\/j.disamonth.2023.101606_bib0076","doi-asserted-by":"crossref","unstructured":"Lichtenstein GR, Ramsey D, Rubin DT. Randomised clinical trial: delayed-release oral mesalazine 4.8 g\/day vs. 2.4 g\/day in endoscopic mucosal healing\u2013ASCEND I and II combined analysis. Aliment Pharmacol Ther 2011; 33:672. doi:10.1111\/j.1365-2036.2010.04575.x.","DOI":"10.1111\/j.1365-2036.2010.04575.x"},{"key":"10.1016\/j.disamonth.2023.101606_bib0077","doi-asserted-by":"crossref","unstructured":"Singh S, Feuerstein JD, Binion DG, Tremaine WJ. AGA technical review on the management of mild-to-moderate ulcerative colitis. Gastroenterology 2019; 156:769. doi:10.1053\/j.gastro.2018.12.008.","DOI":"10.1053\/j.gastro.2018.12.008"},{"key":"10.1016\/j.disamonth.2023.101606_bib0078","doi-asserted-by":"crossref","unstructured":"Sandborn WJ, Travis S, Moro L, et\u00a0al. Once-daily budesonide MMX\u00ae extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Gastroenterology 2012; 143:1218. doi:10.1053\/j.gastro.2012.08.003.","DOI":"10.1053\/j.gastro.2012.08.003"},{"key":"10.1016\/j.disamonth.2023.101606_bib0079","doi-asserted-by":"crossref","unstructured":"Carter MJ, Lobo AJ, Travis SP, IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5:V1. doi:10.1136\/gut.2004.043372.","DOI":"10.1136\/gut.2004.043372"},{"key":"10.1016\/j.disamonth.2023.101606_bib0080","doi-asserted-by":"crossref","unstructured":"Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S. Evaluating upadacitinib in the treatment of moderate-to-severe active ulcerative colitis: design, development, and potential position in therapy. Drug Des Devel Ther. 2022;16:1897-1913. Published 2022 Jun 17. doi:10.2147\/DDDT.S340459.","DOI":"10.2147\/DDDT.S340459"},{"key":"10.1016\/j.disamonth.2023.101606_bib0081","doi-asserted-by":"crossref","unstructured":"Kim DK, Hunter P, Advisory Committee on Immunization Practices. recommended adult immunization schedule, United States, 2019. Ann Intern Med 2019; 170:182. https:\/\/doi.org\/10.7326\/M18-3600.","DOI":"10.7326\/M18-3600"},{"key":"10.1016\/j.disamonth.2023.101606_bib0082","doi-asserted-by":"crossref","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol 2017; 112:241. doi:10.1038\/ajg.2016.537.","DOI":"10.1038\/ajg.2016.537"},{"key":"10.1016\/j.disamonth.2023.101606_bib0083","doi-asserted-by":"crossref","unstructured":"Murthy SK, Feuerstein JD, Nguyen GC, Velayos FS. AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology 2021; 161:1043. doi:10.1053\/j.gastro.2021.05.063.","DOI":"10.1053\/j.gastro.2021.05.063"},{"key":"10.1016\/j.disamonth.2023.101606_bib0084","doi-asserted-by":"crossref","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, et\u00a0al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol 2018; 113:481. doi:10.1038\/ajg.2018.27.","DOI":"10.1038\/ajg.2018.27"},{"key":"10.1016\/j.disamonth.2023.101606_bib0085","doi-asserted-by":"crossref","unstructured":"Andersson P, S\u00f6derholm JD. Surgery in ulcerative colitis: indication and timing. Dig Dis 2009; 27:335. doi:10.1159\/000228570.","DOI":"10.1159\/000228570"},{"key":"10.1016\/j.disamonth.2023.101606_bib0086","doi-asserted-by":"crossref","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, et\u00a0al. Ulcerative colitis. The Lancet 2012; 380:1606. doi:10.1016\/S0140-6736(12)60150-0.","DOI":"10.1016\/S0140-6736(12)60150-0"},{"key":"10.1016\/j.disamonth.2023.101606_bib0087","doi-asserted-by":"crossref","unstructured":"Olecki EJ, Perez Hoguin RA, King S, et\u00a0al. High-grade dysplasia in inflammatory bowel disease: indication for colectomy. Dis Colon Rectum 2023; 66:262. doi:10.1097\/DCR.0000000000002242.","DOI":"10.1097\/DCR.0000000000002242"},{"key":"10.1016\/j.disamonth.2023.101606_bib0088","doi-asserted-by":"crossref","unstructured":"Windsor A, Michetti P, Bemelman W, Ghosh S. The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy. Inflamm Bowel Dis 2013; 19:2695. doi:10.1097\/MIB.0b013e318292fae6.","DOI":"10.1097\/MIB.0b013e318292fae6"},{"key":"10.1016\/j.disamonth.2023.101606_bib0089","doi-asserted-by":"crossref","unstructured":"Cima RR, Pemberton JH. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005; 140:300. doi:10.1001\/archsurg.140.3.300.","DOI":"10.1001\/archsurg.140.3.300"},{"key":"10.1016\/j.disamonth.2023.101606_bib0090","doi-asserted-by":"crossref","unstructured":"Yokoyama T, Masaki T, Ono M, et\u00a0al. Per anal suturing of a bleeding ulcer to achieve successful hemostasis of massive hemorrhage associated with ulcerative colitis: report of two cases. Surg Today 1998; 28:1179. doi:10.1007\/s005950050309.","DOI":"10.1007\/s005950050309"},{"key":"10.1016\/j.disamonth.2023.101606_bib0091","doi-asserted-by":"crossref","unstructured":"Selvasekar CR, Cima RR, Larson DW, et\u00a0al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204:956. doi:10.1016\/j.jamcollsurg.2006.12.044.","DOI":"10.1016\/j.jamcollsurg.2006.12.044"},{"key":"10.1016\/j.disamonth.2023.101606_bib0092","doi-asserted-by":"crossref","unstructured":"Hult\u00e9n L. Proctocolectomy and ileostomy to pouch surgery for ulcerative colitis. World J Surg 1998; 22:335. doi:10.1007\/s002689900393.","DOI":"10.1007\/s002689900393"},{"key":"10.1016\/j.disamonth.2023.101606_bib0093","doi-asserted-by":"crossref","unstructured":"Beyer-Berjot L, Maggiori L, Birnbaum D, et\u00a0al. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg 2013; 258:275. doi:10.1097\/SLA.0b013e3182813741.","DOI":"10.1097\/SLA.0b013e3182813741"},{"key":"10.1016\/j.disamonth.2023.101606_bib0094","doi-asserted-by":"crossref","unstructured":"Marceau C, Alves A, Ouaissi M, et\u00a0al. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients. Surgery 2007; 141:640. doi:10.1016\/j.surg.2006.12.012.","DOI":"10.1016\/j.surg.2006.12.012"},{"key":"10.1016\/j.disamonth.2023.101606_bib0095","doi-asserted-by":"crossref","unstructured":"Chandrasinghe P, Carvello M, Wasmann K, et\u00a0al. Transanal ileal pouch-anal anastomosis for ulcerative colitis has comparable long-term functional outcomes to transabdominal approach: a multicentre comparative study. J Crohns Colitis 2020; 14:726. doi:10.1093\/ecco-jcc\/jjz174.","DOI":"10.1093\/ecco-jcc\/jjz174"},{"key":"10.1016\/j.disamonth.2023.101606_bib0096","doi-asserted-by":"crossref","unstructured":"Remzi FH, Fazio VW, Gorgun E, et\u00a0al. The outcome after restorative proctocolectomy with or without defunctioning ileostomy. Dis Colon Rectum 2006; 49:470. doi:10.1007\/s10350-006-0509-2.","DOI":"10.1007\/s10350-006-0509-2"},{"key":"10.1016\/j.disamonth.2023.101606_bib0097","doi-asserted-by":"crossref","unstructured":"Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res. 2012;160(4):246-257. doi:10.1016\/j.trsl.2012.05.003.","DOI":"10.1016\/j.trsl.2012.05.003"},{"key":"10.1016\/j.disamonth.2023.101606_bib0098","doi-asserted-by":"crossref","unstructured":"Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577-594. doi:10.1053\/j.gastro.2007.11.059.","DOI":"10.1053\/j.gastro.2007.11.059"},{"key":"10.1016\/j.disamonth.2023.101606_bib0099","doi-asserted-by":"crossref","unstructured":"Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34-40. doi:10.1016\/j.mib.2018.07.003.","DOI":"10.1016\/j.mib.2018.07.003"},{"key":"10.1016\/j.disamonth.2023.101606_bib0100","doi-asserted-by":"crossref","unstructured":"Sugihara K, Kamada N. Diet-microbiota interactions in inflammatory bowel disease. Nutrients. 2021;13(5):1533. Published 2021 May 1. doi:10.3390\/nu13051533.","DOI":"10.3390\/nu13051533"},{"key":"10.1016\/j.disamonth.2023.101606_bib0101","doi-asserted-by":"crossref","unstructured":"Kahn SA, Vachon A, Rodriquez D, et\u00a0al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013;19(7):1506-1513. doi:10.1097\/MIB.0b013e318281f520.","DOI":"10.1097\/MIB.0b013e318281f520"},{"key":"10.1016\/j.disamonth.2023.101606_bib0102","doi-asserted-by":"crossref","unstructured":"Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15(8):337. doi:10.1007\/s11894-013-0337-1.","DOI":"10.1007\/s11894-013-0337-1"},{"key":"10.1016\/j.disamonth.2023.101606_bib0103","doi-asserted-by":"crossref","unstructured":"Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis. 2007;44(2):256-262. doi:10.1086\/510385.","DOI":"10.1086\/510385"},{"key":"10.1016\/j.disamonth.2023.101606_bib0104","doi-asserted-by":"crossref","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489-1499. doi:10.1053\/j.gastro.2014.02.009.","DOI":"10.1053\/j.gastro.2014.02.009"},{"key":"10.1016\/j.disamonth.2023.101606_bib0105","doi-asserted-by":"crossref","unstructured":"Ogura Y, Bonen DK, Inohara N, et\u00a0al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603-606. doi:10.1038\/35079114.","DOI":"10.1038\/35079114"},{"key":"10.1016\/j.disamonth.2023.101606_bib0106","doi-asserted-by":"crossref","unstructured":"Swidsinski A, Ladhoff A, Pernthaler A, et\u00a0al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122(1):44-54. doi:10.1053\/gast.2002.30294.","DOI":"10.1053\/gast.2002.30294"},{"key":"10.1016\/j.disamonth.2023.101606_bib0107","doi-asserted-by":"crossref","unstructured":"Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S. Short chain fatty acids and its producing organisms: an overlooked therapy for IBD?. EBioMedicine. 2021;66:103293. doi:10.1016\/j.ebiom.2021.103293.","DOI":"10.1016\/j.ebiom.2021.103293"},{"key":"10.1016\/j.disamonth.2023.101606_bib0108","doi-asserted-by":"crossref","unstructured":"D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114(2):262-267. doi:10.1016\/s0016-5085(98)70476-7.","DOI":"10.1016\/S0016-5085(98)70476-7"},{"key":"10.1016\/j.disamonth.2023.101606_bib0109","doi-asserted-by":"crossref","unstructured":"Manichanh C, Rigottier-Gois L, Bonnaud E, et\u00a0al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55(2):205-211. doi:10.1136\/gut.2005.073817.","DOI":"10.1136\/gut.2005.073817"},{"key":"10.1016\/j.disamonth.2023.101606_bib0110","doi-asserted-by":"crossref","unstructured":"Sepehri S, Kotlowski R, Bernstein CN, Krause DO. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(6):675-683. doi:10.1002\/ibd.20101.","DOI":"10.1002\/ibd.20101"},{"key":"10.1016\/j.disamonth.2023.101606_bib0111","unstructured":"Iwaya A, Iiai T, Okamoto H, et\u00a0al. Change in the bacterial flora of pouchitis. Hepatogastroenterology. 2006;53(67):55-59."},{"key":"10.1016\/j.disamonth.2023.101606_bib0112","doi-asserted-by":"crossref","unstructured":"Roda G, Jharap B, Neeraj N, Colombel JF. Loss of response to anti-TNFs: definition, epidemiology, and management. Clin Transl Gastroenterol. 2016;7(1):e135. Published 2016 Jan 7. doi:10.1038\/ctg.2015.63.","DOI":"10.1038\/ctg.2015.63"},{"key":"10.1016\/j.disamonth.2023.101606_bib0113","doi-asserted-by":"crossref","unstructured":"Mo\u0107ko P, Kawalec P, Pilc A. Safety profile of biologic drugs in the treatment of inflammatory bowel diseases: a systematic review and network meta-analysis of randomized controlled trials. Clin Drug Investig. 2017;37(1):25-37. doi:10.1007\/s40261-016-0459-y.","DOI":"10.1007\/s40261-016-0459-y"},{"key":"10.1016\/j.disamonth.2023.101606_bib0114","doi-asserted-by":"crossref","unstructured":"Crothers J. Gastroenterology. 2018;154:S-1050. (Abstract). dOI:10.1016\/S0016-5085(18)33519-4.","DOI":"10.1016\/S0016-5085(18)33519-4"},{"key":"10.1016\/j.disamonth.2023.101606_bib0115","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Surette MG, Kim PT, et\u00a0al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102-109.e6. doi:10.1053\/j.gastro.2015.04.001.","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"10.1016\/j.disamonth.2023.101606_bib0116","doi-asserted-by":"crossref","unstructured":"Rossen NG, Fuentes S, van der Spek MJ, et\u00a0al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110-118.e4. doi:10.1053\/j.gastro.2015.03.045.","DOI":"10.1053\/j.gastro.2015.03.045"},{"key":"10.1016\/j.disamonth.2023.101606_bib0117","doi-asserted-by":"crossref","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, et\u00a0al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218-1228. doi:10.1016\/S0140-6736(17)30182-4.","DOI":"10.1016\/S0140-6736(17)30182-4"},{"key":"10.1016\/j.disamonth.2023.101606_bib0118","doi-asserted-by":"crossref","unstructured":"Costello SP, Hughes PA, Waters O, et\u00a0al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156-164. doi:10.1001\/jama.2018.20046.","DOI":"10.1001\/jama.2018.20046"},{"key":"10.1016\/j.disamonth.2023.101606_bib0119","doi-asserted-by":"crossref","unstructured":"B\u0159ezina J, Bajer L, Wohl P, et\u00a0al. Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis-results of a randomized controlled trial. J Clin Med. 2021;10(13):2753. Published 2021 Jun 22. doi:10.3390\/jcm10132753.","DOI":"10.3390\/jcm10132753"},{"key":"10.1016\/j.disamonth.2023.101606_bib0120","doi-asserted-by":"crossref","unstructured":"Crothers JW, Chu ND, Nguyen LTT, et\u00a0al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 2021;21(1):281. Published 2021 Jul 8. doi:10.1186\/s12876-021-01856-9.","DOI":"10.1186\/s12876-021-01856-9"},{"key":"10.1016\/j.disamonth.2023.101606_bib0121","doi-asserted-by":"crossref","unstructured":"Pai N, Popov J, Hill L, et\u00a0al. Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects. Gastroenterology. 2021;161(2):388-393.e3. doi:10.1053\/j.gastro.2021.04.067.","DOI":"10.1053\/j.gastro.2021.04.067"},{"key":"10.1016\/j.disamonth.2023.101606_bib0122","doi-asserted-by":"crossref","unstructured":"Shabat C, Scaldaferri F, Zittan E, et\u00a0al. Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial. J Crohns Colitis. 2022;16(3):369-378. doi:10.1093\/ecco-jcc\/jjab165.","DOI":"10.1093\/ecco-jcc\/jjab165"},{"key":"10.1016\/j.disamonth.2023.101606_bib0123","doi-asserted-by":"crossref","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, et\u00a0al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141-151. doi:10.1016\/S2468-1253(21)00400-3.","DOI":"10.1016\/S2468-1253(21)00400-3"},{"key":"10.1016\/j.disamonth.2023.101606_bib0124","doi-asserted-by":"crossref","unstructured":"Vermeire S, Joossens M, Verbeke K, et\u00a0al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis. 2016;10(4):387-394. doi:10.1093\/ecco-jcc\/jjv203.","DOI":"10.1093\/ecco-jcc\/jjv203"},{"key":"10.1016\/j.disamonth.2023.101606_bib0125","doi-asserted-by":"crossref","unstructured":"Keshteli AH, Millan B, Madsen KL. Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis. Mucosal Immunol. 2017;10(2):565-566. doi:10.1038\/mi.2016.123.","DOI":"10.1038\/mi.2016.123"},{"key":"10.1016\/j.disamonth.2023.101606_bib0126","doi-asserted-by":"crossref","unstructured":"Chu ND, Smith MB, Perrotta AR, Kassam Z, Alm EJ. Profiling living bacteria informs preparation of fecal microbiota transplantations. PLoS One. 2017;12(1):e0170922. Published 2017 Jan 26. doi:10.1371\/journal.pone.0170922.","DOI":"10.1371\/journal.pone.0170922"},{"key":"10.1016\/j.disamonth.2023.101606_bib0127","doi-asserted-by":"crossref","unstructured":"Wang S, Xu M, Wang W, et\u00a0al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One. 2016;11(8):e0161174. Published 2016 Aug 16. doi:10.1371\/journal.pone.0161174.","DOI":"10.1371\/journal.pone.0161174"},{"key":"10.1016\/j.disamonth.2023.101606_bib0128","doi-asserted-by":"crossref","unstructured":"Kelly CR, Yen EF, Grinspan AM, et\u00a0al. Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry. Gastroenterology. 2021;160(1):183-192.e3. doi:10.1053\/j.gastro.2020.09.038.","DOI":"10.1053\/j.gastro.2020.09.038"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150292300086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001150292300086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:04:37Z","timestamp":1757898277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001150292300086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":128,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S001150292300086X"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2023.101606","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulcerative colitis: Addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2023.101606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101606"}}